サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1772265

トレムフィアの市場規模、シェア、動向分析レポート：用途別、流通チャネル別、地域別、セグメント予測、2025年～2033年

Tremfya Market Size, Share & Trends Analysis Report By Application (Plaque Psoriasis, Psoriatic Arthritis (PsA)), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
トレムフィアの市場規模、シェア、動向分析レポート：用途別、流通チャネル別、地域別、セグメント予測、2025年～2033年
出版日: 2025年06月27日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

トレムフィア市場サマリー

トレムフィアの世界市場規模は2024年に36億7,000万米ドルと推計され、2033年には72億9,000万米ドルに達すると予測され、2025年から2033年までのCAGRは7.60%で成長します。慢性尋常性乾癬と関節症性乾癬の有病率の増加は、高度生物学的製剤の需要を拡大させています。

これらの自己免疫疾患は世界的に増加し続けており、その結果、効果的かつ長期的な治療オプションに対するニーズが高まっています。インターロイキン-23（IL-23）を標的とするモノクローナル抗体であるトレムフィアは、中等度から重度の症例において強い有効性と持続的な結果をもたらしています。その一貫した臨床成績と良好な安全性プロファイルは、皮膚科医やリウマチ専門医の間で受け入れられつつあります。

ヤンセン・ファーマシューティカルズの強力な市場戦略と競合ポジショニングが、トレムフィアの商業的成功を後押ししています。この薬剤は、TNF阻害剤やIL-17阻害剤を含むいくつかの既存の生物学的製剤と比較して、優れた有効性データによって差別化されています。真っ向から比較した試験では、トレムフィヤの迅速な皮膚クリアランスと持続的な奏効を達成する能力が示されており、治療状況において戦略的優位性を与えています。例えば、2024年10月、ジョンソン・エンド・ジョンソンのSPECTREM試験では、トレムフィヤが頭皮、顔、手、足、性器などの乾癬困難部位を効果的にクリアし、クリア率は最大80％であることが示されました。ほとんどの患者は、48週目まで透明またはほぼ透明な皮膚を維持した。この治療はまた、かゆみや痛みなどの症状を軽減し、患者のQOLを著しく改善しました。

現在進行中の臨床研究とライフサイクルマネジメントの取り組みが、トレムフィア市場の今後の成長を支えています。新たな臨床試験では、治療範囲を大幅に広げる可能性のある、汗腺膿瘍やクローン病などの適応拡大が検討されています。この薬剤のメーカーは、多様な集団における有効性を検証するため、実臨床試験にも投資しています。精密医療とバイオマーカー主導型治療への関心の高まりは、個別化治療レジメンにおけるIL-23阻害剤の関連性を高めています。専門薬局との提携と合理化された流通網により、需要の高い市場での入手性が向上しています。また、医師教育や患者支援プログラムに継続的に注力することで、ブランドロイヤルティを強化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 トレムフィア市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
    • パイプライン分析
    • 特許満了分析
    • 価格分析

第4章 トレムファヤ市場：用途のビジネス分析

  • 用途市場シェア、2024年および2033年
  • 用途セグメントダッシュボード
  • 市場規模、予測、動向分析（用途別、2021～2033年）
  • 尋常性乾癬
  • 乾癬性関節炎（PsA）
  • その他

第5章 トレムフィア市場：流通チャネルのビジネス分析

  • 流通チャネル市場シェア、2024年および2033年
  • 流通チャネルセグメントダッシュボード
  • 市場規模、予測、動向分析（流通チャネル別、2021～2033年）
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第6章 トレムフィア市場：地域の推定・動向分析

  • 地域別市場シェア分析、2024年および2033年
  • 地域市場ダッシュボード
  • 市場規模と予測動向分析、2021～2033年：
  • 北米
    • 国別、2021年～2033年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Johnson &Johnson Services, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Tremfya market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 North America Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 8 North America Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9 U.S. Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 Canada Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 12 Canada Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Europe Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 17 Europe Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 UK Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 19 UK Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 France Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 23 France Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24 Italy Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 25 Italy Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 Spain Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 27 Spain Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 Norway Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 29 Norway Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30 Denmark Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 31 Denmark Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Sweden Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 33 Sweden Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37 Japan Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 38 Japan Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39 China Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 40 China Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 India Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 42 India Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 43 Australia Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 44 Australia Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45 South Korea Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 46 South Korea Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47 Thailand Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 48 Thailand Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 49 Latin America Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 51 Latin America Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52 Brazil Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 53 Brazil Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 Argentina Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 55 Argentina Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59 South Africa Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 60 South Africa Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 UAE Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 64 UAE Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Tremfya market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Tremfya market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Tremfya market dynamics
  • Fig. 12 Tremfya market: Porter's five forces analysis
  • Fig. 13 Tremfya market: PESTLE analysis
  • Fig. 14 Application market, 2021 - 2033 (USD Million)
  • Fig. 15 Plaque Psoriasis market, 2021 - 2033 (USD Million)
  • Fig. 16 Psoriatic Arthritis (PsA) market, 2021 - 2033 (USD Million)
  • Fig. 17 Others market, 2021 - 2033 (USD Million)
  • Fig. 18 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 19 Hospital Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 20 Retail Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 21 Online Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 22 Tremfya market revenue, by region
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 North America Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. country dynamics
  • Fig. 26 U.S. Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 27 Canada country dynamics
  • Fig. 28 Canada Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 29 Mexico country dynamics
  • Fig. 30 Mexico Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 31 Europe Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 32 UK country dynamics
  • Fig. 33 UK Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 34 Germany country dynamics
  • Fig. 35 Germany Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 36 France country dynamics
  • Fig. 37 France Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 38 Italy country dynamics
  • Fig. 39 Italy Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 40 Spain country dynamics
  • Fig. 41 Spain Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 42 Norway country dynamics
  • Fig. 43 Norway Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 44 Sweden country dynamics
  • Fig. 45 Sweden Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark country dynamics
  • Fig. 47 Denmark Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 48 Asia Pacific Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 49 Japan country dynamics
  • Fig. 50 Japan Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 51 China country dynamics
  • Fig. 52 China Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 53 India country dynamics
  • Fig. 54 India Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 55 Australia country dynamics
  • Fig. 56 Australia Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea country dynamics
  • Fig. 58 South Korea Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand country dynamics
  • Fig. 60 Thailand Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil country dynamics
  • Fig. 63 Brazil Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 64 Argentina country dynamics
  • Fig. 65 Argentina Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 66 MEA Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 67 South Africa country dynamics
  • Fig. 68 South Africa Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 69 Saudi Arabia country dynamics
  • Fig. 70 Saudi Arabia Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 71 UAE country dynamics
  • Fig. 72 UAE Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 73 Kuwait country dynamics
  • Fig. 74 Kuwait Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 75 Company categorization
  • Fig. 76 Company market position analysis
  • Fig. 77 Strategic framework
目次
Product Code: GVR-4-68040-648-6

Tremfya Market Summary

The global tremfya market size was estimated at USD 3.67 billion in 2024 and is projected to reach USD 7.29 billion by 2033, growing at a CAGR of 7.60% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greater demand for advanced biologic therapies.

These autoimmune conditions continue to rise globally, resulting in a growing need for effective and long-term treatment options. Tremfya, a monoclonal antibody that targets interleukin-23 (IL-23), has delivered strong efficacy and durable outcomes in moderate-to-severe cases. Its consistent clinical performance and favorable safety profile have strengthened its acceptance among dermatologists and rheumatologists.

Janssen Pharmaceuticals ' strong marketing strategies and competitive positioning drive Tremfya's commercial success. The drug has differentiated itself through superior efficacy data compared to some existing biologics, including TNF and IL-17 inhibitors. Head-to-head studies have shown Tremfya's ability to achieve rapid skin clearance and sustained response, giving it a strategic advantage in the treatment landscape. For instance, In October 2024, Johnson & Johnson's SPECTREM study showed Tremfya effectively cleared difficult psoriasis areas like the scalp, face, hands, feet, and genitals, with clearance rates up to 80%. Most patients maintained clear or almost clear skin through week 48. The treatment also significantly improved patients' quality of life by reducing symptoms like itch and pain.

Ongoing clinical research and lifecycle management initiatives support the Tremfya market's future growth. New clinical trials are exploring expanded applications, such as hidradenitis suppurativa and Crohn's disease, which could significantly widen its therapeutic scope. The drug's manufacturer also invests in real-world evidence studies to validate its effectiveness in diverse populations. The growing interest in precision medicine and biomarker-driven therapies is increasing the relevance of IL-23 inhibitors in personalized treatment regimens. Partnerships with specialty pharmacies and streamlined distribution networks enhance availability in high-demand markets. The company's continued focus on physician education and patient support programs reinforces brand loyalty.

Global Tremfya Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global Tremfya market report based on application, distribution channel and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Plaque Psoriasis
  • Psoriatic Arthritis (PsA)
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Tremfya Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Tremfya Market: Application Business Analysis

  • 4.1. Application Market Share, 2024 & 2033
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Plaque Psoriasis
    • 4.4.1. Plaque Psoriasis Market, 2021 - 2033 (USD Million)
  • 4.5. Psoriatic Arthritis (PsA)
    • 4.5.1. Psoriatic Arthritis (PsA) Market, 2021 - 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Tremfya Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2033
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
  • 5.6. Online Pharmacies
    • 5.6.1. Online Pharmacies Market, 2021 - 2033 (USD Million)

Chapter 6. Tremfya Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Tremfya Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Johnson & Johnson Services, Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Application Benchmarking
      • 7.5.1.4. Strategic Initiatives